Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cd11b and Cd56 as Prognostic Markers in Acute Myeloid Leukemia

NCT03283228 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03283228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03283228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cd11b and Cd56 as Prognostic Markers in Acute Myeloid Leukemia
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2017
Completion date
October 1, 2019
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adult acute myeloid leukemia